Mobia Medical

Paired Vagus Nerve Stimulation (Paired VNS™) Platform

Headquartered in Texas, MicroTransponder Inc. has developed the Paired Vagus Nerve Stimulation (Paired VNS™) platform; the Vivistim® system is the first FDA-approved system on the platform for treatment of post-stroke upper limb impairment.

Visit Mobia Medical

Partnerships

Team+1 more

Adrian Gale

Vice President, Strategic Business Operations

Team

Categories:

Managed Service Provider (MSP)

Similar to Mobia Medical

View all companies

Developer of an implantable neurostimulation device designed to aid stroke recovery, and other neurological disorders. The company's device incorporates paired vagus nerve stimulation and wireless technology to deliver targeted electrical impulses, enhancing neuroplasticity, and restoring motor function in post-stroke patients, enabling healthcare practitioners to improve patient outcomes.

Austin, United StatesOther